After bravely and stoically battling Neuroendocrine Cancer for nearly 3 years, Charlie Everton finally succumbed to the disease on 21st September 2019. His treatment at the Christie Hospital had helped to prolong the quality time that he spent with his family, friends and loved ones, for which we are all eternally grateful. The treatment could not however, save his life and we have lost our wonderful, courageous, compassionate and beautiful son, brother and friend to this awful disease. His smile and laughter could light up any room and we, like many others will miss him terribly.
As with most types of cancer, our understanding of its epidemiology, development, genetic behaviour and biochemistry is improving, but we are still losing far too many young people like Charlie to the disease each year. This is not acceptable in the 21st century and needs addressing on an international scale by governments, drug companies and research institutions alike. Cancer is a leading cause of death worldwide, accounting for an estimated 9.6 million deaths in 2018, and, whilst the mortality rate is reducing, set against an increase in the detection and earlier diagnosis of the disease, it still represents as greater a threat to the human species as climate change.
Whilst finding and developing a range of better and more incisive treatments is not solely dependant on money, there is no doubt that research and development of various therapies requires huge capital investment and revenue support. It also requires incentive! So what better reason could there be than fighting cancer in the young?
Finding a cure for cancer, in its various forms and individual mutations, is perhaps an impossible dream, the "holy grail" too far. The disease presents in many different guises and is able to mutate and cloak itself from the drugs administered to constrain its spread. Our universal target therefore should be to prolong life and to enable people like Charlie to live with cancer to a later age, contributing to society and, where they choose, perhaps have children themselves.
The Christie Hospital has a team, led by Professor Juan Valle, who are at the forefront of combatting the type of cancer from which Charlie suffered. A cancer which does not discriminate its victims by their age. Charlie was a hugely well loved person who possessed much to give to our world but was denied. He lived life to the full and he touched so many people in the process. We feel compelled not let his death pass without it helping to make life better for others.
Therefore I ask you to please give whatever amount you wish, however large or small a donation, to this worthwhile organisation which is at the forefront of research into the disease.
We intend to run this page for as long as it takes to raise our initial target and then continue to make a contribution to fighting this disease. We are encouraging his friends and others to participate in continuing to push forward our theme. "Too many - too young".
In Charlie's honour and with our love.
Please visit his web-site, www.charlieeverton.co.uk
or email:- email@example.com